DK1003903T3 - Fremgangsmåde til fremstilling af enantiomerisk berigede N-derivatiserede lactamer - Google Patents

Fremgangsmåde til fremstilling af enantiomerisk berigede N-derivatiserede lactamer

Info

Publication number
DK1003903T3
DK1003903T3 DK98951307T DK98951307T DK1003903T3 DK 1003903 T3 DK1003903 T3 DK 1003903T3 DK 98951307 T DK98951307 T DK 98951307T DK 98951307 T DK98951307 T DK 98951307T DK 1003903 T3 DK1003903 T3 DK 1003903T3
Authority
DK
Denmark
Prior art keywords
lactams
derivatized
preparation
enantiomerically enriched
enantiomerically
Prior art date
Application number
DK98951307T
Other languages
Danish (da)
English (en)
Inventor
Michael John Dawson
Mahmoud Mahmoudian
Christopher John Wallis
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1003903T3 publication Critical patent/DK1003903T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/02Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DK98951307T 1997-08-22 1998-08-20 Fremgangsmåde til fremstilling af enantiomerisk berigede N-derivatiserede lactamer DK1003903T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9717928.7A GB9717928D0 (en) 1997-08-22 1997-08-22 Process for the enatioselective hydrolysis of n-derivatised lactams
PCT/EP1998/005291 WO1999010519A1 (en) 1997-08-22 1998-08-20 Process for preparing enantiomerically enriched n-derivatised lactams

Publications (1)

Publication Number Publication Date
DK1003903T3 true DK1003903T3 (da) 2003-06-10

Family

ID=10817952

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98951307T DK1003903T3 (da) 1997-08-22 1998-08-20 Fremgangsmåde til fremstilling af enantiomerisk berigede N-derivatiserede lactamer

Country Status (35)

Country Link
US (1) US6340587B1 (sh)
EP (1) EP1003903B1 (sh)
JP (1) JP3565868B2 (sh)
KR (1) KR100479894B1 (sh)
CN (1) CN1133749C (sh)
AP (1) AP1104A (sh)
AR (1) AR016395A1 (sh)
AT (1) ATE233323T1 (sh)
AU (1) AU738897B2 (sh)
BR (1) BR9810472B1 (sh)
CA (1) CA2295017A1 (sh)
CZ (1) CZ294302B6 (sh)
DE (1) DE69811677T2 (sh)
DK (1) DK1003903T3 (sh)
EA (1) EA001964B1 (sh)
EE (1) EE03934B1 (sh)
ES (1) ES2193568T3 (sh)
GB (1) GB9717928D0 (sh)
HK (1) HK1025796A1 (sh)
HR (1) HRP990408B1 (sh)
HU (1) HU222657B1 (sh)
ID (1) ID25830A (sh)
IL (1) IL133541A (sh)
IN (1) IN183908B (sh)
IS (1) IS2201B (sh)
NO (1) NO320081B1 (sh)
NZ (1) NZ501880A (sh)
PL (1) PL191108B1 (sh)
PT (1) PT1003903E (sh)
RS (1) RS49542B (sh)
SI (1) SI1003903T1 (sh)
SK (1) SK282782B6 (sh)
TR (1) TR199903210T2 (sh)
TW (1) TW589301B (sh)
WO (1) WO1999010519A1 (sh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2214876T3 (es) 1998-07-09 2004-09-16 Lonza Ag Procedimiento de preparacion de derivaods de (1r,4s)-2-azabiciclo 2.2.1 hept-5-en-3-ona.
DE19962543A1 (de) 1999-12-23 2001-07-05 Degussa Chromatographische Enantiomerentrennung von bicyclischen Lactamen
US6780635B2 (en) 2001-12-27 2004-08-24 Council Of Scientific And Industrial Research Process for the preparation of optically active azabicyclo heptanone derivatives
DE60211646T2 (de) * 2002-03-28 2007-05-24 Council Of Scientific And Industrial Research Verfahren zur Herstellung von optisch aktiven Azabicycloheptanone-Derivaten
HU227663B1 (en) * 2007-07-09 2011-10-28 Univ Szegedi Resolution process
KR20170078868A (ko) 2010-01-27 2017-07-07 비이브 헬쓰케어 컴퍼니 항바이러스 치료
CN103695495B (zh) * 2014-01-14 2014-08-27 营口三征新科技化工有限公司 一种制备(1R,4s)-(-)-2-氮杂双环[2,2,1]庚-5-烯-3-酮的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69016739T2 (de) * 1989-10-16 1995-06-14 Chiroscience Ltd Chirale Azabicycloheptanone und Verfahren zu ihrer Herstellung.
GB9108384D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Bicycloheptanes
SK284810B6 (sk) * 1997-05-13 2005-12-01 Lonza Ag Spôsob výroby (1S,4R)- alebo (1R,4S)-4-(2-amino-6-chlór-9-H- purín-9-yl)-2-cyklopentén-1-metanolu

Also Published As

Publication number Publication date
GB9717928D0 (en) 1997-10-29
CN1133749C (zh) 2004-01-07
BR9810472B1 (pt) 2011-01-11
CA2295017A1 (en) 1999-03-04
IS2201B (is) 2007-02-15
AP9901721A0 (en) 1999-12-31
HK1025796A1 (en) 2000-11-24
HUP0002661A2 (hu) 2000-12-28
NO996368L (no) 2000-02-21
IL133541A0 (en) 2001-04-30
IS5297A (is) 1999-12-14
RS49542B (sr) 2007-02-05
PL191108B1 (pl) 2006-03-31
ID25830A (id) 2000-11-09
EP1003903A1 (en) 2000-05-31
EA001964B1 (ru) 2001-10-22
JP3565868B2 (ja) 2004-09-15
BR9810472A (pt) 2000-09-19
AR016395A1 (es) 2001-07-04
AU738897B2 (en) 2001-09-27
SK184499A3 (en) 2000-09-12
SI1003903T1 (en) 2003-08-31
AU9738698A (en) 1999-03-16
TR199903210T2 (xx) 2000-07-21
EA199901059A1 (ru) 2000-08-28
EE200000075A (et) 2000-10-16
US6340587B1 (en) 2002-01-22
KR20010014078A (ko) 2001-02-26
CN1261405A (zh) 2000-07-26
CZ294302B6 (cs) 2004-11-10
EP1003903B1 (en) 2003-02-26
DE69811677D1 (de) 2003-04-03
CZ471699A3 (cs) 2000-06-14
NO320081B1 (no) 2005-10-17
HU222657B1 (hu) 2003-09-29
HRP990408B1 (en) 2006-05-31
IL133541A (en) 2003-10-31
SK282782B6 (sk) 2002-12-03
YU69399A (sh) 2002-06-19
ES2193568T3 (es) 2003-11-01
NZ501880A (en) 2001-08-31
PL337647A1 (en) 2000-08-28
DE69811677T2 (de) 2003-10-16
TW589301B (en) 2004-06-01
HRP990408A2 (en) 2000-04-30
AP1104A (en) 2002-09-04
PT1003903E (pt) 2003-06-30
HUP0002661A3 (en) 2001-12-28
JP2001504354A (ja) 2001-04-03
WO1999010519A1 (en) 1999-03-04
ATE233323T1 (de) 2003-03-15
KR100479894B1 (ko) 2005-03-30
IN183908B (sh) 2000-05-13
EE03934B1 (et) 2002-12-16
NO996368D0 (no) 1999-12-21

Similar Documents

Publication Publication Date Title
DK1032566T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK0857784T3 (da) Fremgangsmåde til fremstilling af L-lysin
DK0811682T3 (da) Fremgangsmåde til fremstilling af L-lysin
DK0854189T3 (da) Fremgangsmåde til fremstilling af L-lysin
DK0754756T3 (da) Fremgangsmåde til fremstilling af L-lysin
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1005517T3 (da) Fremgangsmåde til fremstilling af diglycerider
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK1005444T3 (da) Fremgangsmåde til fremstilling af aromatiske aminer
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0912603T3 (da) Fremgangsmåde til fremstilling af visse azacyclohexapeptider
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK1003903T3 (da) Fremgangsmåde til fremstilling af enantiomerisk berigede N-derivatiserede lactamer
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK0906255T3 (da) Fremgangsmåde til fremstilling af enantiomert ren azetidin-2-carboxylsyre
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0840724T3 (da) Fremgangsmåde til fremstilling af enantiomerisk ren azetidin-2-caboxylsyre
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer